Lysergic acid is a naturally occurring compound produced primarily by ergot fungi and a handful of symbiotic plant-fungus partnerships. It sits at the center of an unusually wide range of human interests: it is the chemical backbone of LSD, the precursor to drugs that stop postpartum bleeding, the active scaffold in migraine medications, and a molecule whose derivatives have shaped cultures and poisoned civilizations. Despite its notoriety as the parent structure of a famous psychedelic, lysergic acid itself is not hallucinogenic. Its importance lies in what chemists can attach to it, and in what nature already has.
Where Lysergic Acid Comes From
The primary natural source is the Claviceps genus of fungi, commonly known as ergot. These fungi parasitize cereal grains, especially rye, replacing the grain kernel with a dark, hardened mass called a sclerotium. That mass is loaded with ergot alkaloids, a family of compounds that all share the lysergic acid core. The fungi produce lysergic acid through an eight-enzyme pathway that starts with the amino acid tryptophan and, through a series of oxidations and rearrangements, builds the characteristic four-ring ergoline structure.1Nature Communications. Reconstituting the complete biosynthesis of D-lysergic acid in yeast
Ergot fungi are not the only source. Morning glories in the family Convolvulaceae harbor symbiotic fungi called Periglandula species that produce high concentrations of ergot alkaloids in seeds. These concentrations can be remarkably high, up to a thousand-fold greater than those found in endophyte-infected grasses.2PubMed. Differential allocation of seed-borne ergot alkaloids during early ontogeny of morning glories (Convolvulaceae) A large-scale survey of morning glory species found that about a quarter of the species tested contained ergot alkaloids in their seeds, with 36 species being newly identified as carriers.3Communications Biology. Diversification of ergot alkaloids and heritable fungal symbionts in morning glories The fungi are transmitted from parent plant to offspring through the seeds themselves, a vertical inheritance that keeps the symbiosis going across generations. When researchers grew morning glory plants in a glasshouse, they still found ergot alkaloids like ergine (a lysergic acid amide) in the plant tissue, though at concentrations roughly twelve-fold lower than in the seeds.4PubMed Central. Identification and determination of ergot alkaloids in Morning Glory cultivars
The evolutionary logic behind these partnerships seems to be defense. Plants laden with ergot alkaloids are less palatable to herbivores. The fungi benefit from a stable home, and the plant benefits from chemical protection. The genes responsible for building ergot alkaloids have diversified through duplication and rearrangement over evolutionary time, giving rise to a wide variety of structures including simple clavines, lysergic acid amides, and complex ergopeptines.5PubMed Central. Ergot Alkaloids of the Family Clavicipitaceae
Why It Matters in Medicine
Lysergic acid is not used as a drug on its own, but derivatives built from it have been cornerstones of several medical fields for decades. The modifications are straightforward in concept: attach different chemical groups to lysergic acid’s carboxyl position and you get compounds with dramatically different biological effects. Three families of derivatives have had the most impact.
Ergotamine and its reduced form, dihydroergotamine, were once the standard treatment for acute migraine. They work by binding tightly to specific serotonin receptors (5-HT1B and 5-HT1D) that constrict the dilated blood vessels surrounding the brain and quiet overactive nerve signaling in the trigeminal system. Because they are so potent at these receptors, the doses needed are very small.6PubMed. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy Triptans have largely replaced ergotamine for most migraine sufferers because they are more targeted and produce fewer side effects, but dihydroergotamine still sees use for severe or treatment-resistant attacks, particularly as a nasal spray or injection.
Ergometrine (also called ergonovine) is a lysergic acid amide derivative that causes strong uterine contractions. It is recommended for the prevention and management of postpartum hemorrhage, which remains one of the leading causes of maternal death worldwide.7PubMed. A Role for Adrenergic Receptors in the Uterotonic Effects of Ergometrine in Isolated Human Term Nonlaboring Myometrium A recent clinical study found that combining ergometrine maleate with calcium gluconate reduced postpartum blood loss, shortened hemostasis time, and improved hemoglobin levels compared to standard approaches.8PubMed. Clinical Efficacy of Calcium Gluconate Combined With Ergometrine Maleate in the Prevention of Uterine Atony-Induced Postpartum Hemorrhage and Their Effects on Coagulation Function The drug is not without risk; its ability to constrict blood vessels extends beyond the uterus, and cases of heart-related complications including myocardial ischemia have been documented.9PubMed Central. Ergometrine for postpartum hemorrhage and associated myocardial ischemia: Two case reports and a review of the literature
Bromocriptine and cabergoline are lysergic acid derivatives that act as dopamine agonists. They are the primary treatments for prolactinomas, benign pituitary tumors that overproduce the hormone prolactin. By mimicking dopamine at the pituitary gland, these drugs suppress prolactin secretion and shrink the tumors.10PubMed Central. The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas Bromocriptine has also been used to treat Parkinson’s disease, though newer dopamine agonists have taken over most of that role.
The LSD Connection
Lysergic acid diethylamide, better known as LSD, is made by attaching a diethylamide group to lysergic acid. Albert Hofmann first synthesized it in 1938 at Sandoz Laboratories while working on ergot derivatives, and accidentally discovered its extraordinary potency as a psychoactive agent five years later. LSD acts at vanishingly small doses, measured in millionths of a gram, making it one of the most potent psychoactive substances known.
The pharmacology of LSD revolves around serotonin receptors, particularly 5-HT2A. Crystal structures of LSD bound to the serotonin 2A receptor show that a loop of the receptor protein folds over the molecule like a lid, trapping it in the binding pocket and slowing its release. This prolonged residence time helps explain why LSD’s effects last so long, often eight to twelve hours from a single dose.11Cell. Structure of a 5-HT2A Serotonin Receptor–Gq Complex A 2025 study comparing psychedelics with non-hallucinogenic analogs found that the hallucinogenic effect specifically requires 5-HT2A receptor activation of a non-canonical signaling pathway. Non-hallucinogenic analogs of LSD that activate the same receptor through a different route do not produce psychedelic effects, suggesting that how the receptor is switched on matters as much as whether it is switched on.12Nature. Psychedelics elicit their effects by 5-HT2A receptor-mediated Gi signalling
But serotonin is not the whole story. LSD and its structural relatives also bind to dopamine receptors. Testing showed that LSD’s affinity for dopamine D2 receptors was roughly similar to its affinity for 5-HT2 serotonin receptors, and its affinity for D1 receptors was only modestly lower.13PubMed. LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors This messy, multi-receptor profile is characteristic of ergoline compounds generally and is precisely what makes lysergic acid derivatives so pharmacologically versatile, and so difficult to engineer into clean, targeted drugs.
Recent work has tried to simplify the picture. Researchers systematically stripped away parts of LSD’s four-ring structure to create simplified analogs and tested each one for receptor activity. This approach identified the minimal molecular features needed to produce full activation of the 5-HT2A receptor and hallucinogenic behavior, potentially opening the door to designing compounds that retain therapeutic effects while discarding unwanted ones.14PubMed Central. Deconstruction of lysergic acid diethylamide
Ergotism and the History of Accidental Poisoning
Long before anyone isolated lysergic acid, its effects were being felt through contaminated grain. Ergotism, caused by eating bread made from ergot-infected rye, was a recurring catastrophe in medieval Europe. The disease took two forms: convulsive ergotism, marked by seizures and hallucinations, and gangrenous ergotism, in which the vasoconstricting effects of ergot alkaloids cut off blood flow to the extremities, causing fingers, toes, and limbs to blacken and die. The gangrenous form was called “St. Anthony’s fire,” a name that was also applied to at least two unrelated infectious diseases, erysipelas and herpes zoster, creating confusion that persisted for centuries.15PubMed Central. One holy man, one eponym, three distinct diseases. St. Anthony’s fire revisited
Morning glory seeds had a very different cultural trajectory. In Mesoamerica, seeds of Turbina corymbosa (known as ololiuhqui in Nahuatl) were used ceremonially by Aztec priests to produce hallucinogenic visions. These seeds contain lysergic acid amide, a simpler derivative that shares structural features with LSD. Spanish colonial authorities considered these ceremonies satanic and persecuted practitioners, driving the use of ololiuhqui underground.16PLoS ONE. Psychoactive and other ceremonial plants from a 2,000-year-old Maya ritual deposit at Yaxnohcah, Mexico The seeds were not recognized as containing ergot-related compounds by Western science until the 1960s, when Hofmann himself analyzed them and was surprised to find lysergic acid amides in a plant source.
Lysergic Acid Amide Versus LSD
Lysergic acid amide (also called ergine, or LSA) is the compound most commonly found in morning glory and Hawaiian baby woodrose seeds. People sometimes consume these seeds recreationally expecting an experience similar to LSD, but the pharmacology is meaningfully different. In binding assays, LSA showed clear affinity for 5-HT1A and 5-HT2 serotonin receptors and for alpha-2 adrenergic receptors, but its binding strength was lower than LSD across every receptor subtype tested. LSA’s dopamine receptor affinity was also weaker.17PubMed. Argyreia nervosa (Burm. f.): receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches In practical terms, this means LSA produces milder psychoactive effects and is accompanied by more pronounced side effects from the other alkaloids present in the seeds, including nausea, sedation, and muscle cramping. It is not simply a weaker version of LSD; it is a different pharmacological experience entirely.
The Problem for Livestock
Ergot alkaloids are not just a historical curiosity in agriculture. Tall fescue grass, one of the most widely planted pasture grasses in the eastern United States, commonly harbors an endophytic fungus that produces ergot alkaloids. When cattle graze on infected fescue, they develop a syndrome called fescue toxicosis. Symptoms include poor weight gain, elevated body temperature, restricted blood flow to the extremities, and reduced milk production. The economic losses are substantial.
For years, ergovaline was assumed to be the main culprit. But research has complicated that picture. When researchers tracked what happened to ergot alkaloids in the rumen, they found that microbial metabolism broke down the more complex alkaloids, and the total alkaloid concentration actually increased over time. The key finding was that only lysergic acid crossed the gastric barriers in their transport experiments. Ergovaline was not detected in ruminal fluid or urine, while a signal consistent with lysergic acid was found in the urine of steers grazing infected pasture.18Crop Science. Ruminal Metabolism and Transport of Tall Fescue Ergot Alkaloids Separate work confirmed that lysergic acid could be detected in ruminal fluid and urine at levels above the analytical limits in steers fed diets containing ergovaline, supporting the idea that lysergic acid is bioavailable and potentially involved in the toxicosis syndrome.19PubMed. Detection of lysergic acid in ruminal fluid, urine, and in endophyte-infected tall fescue using high-performance liquid chromatography
The implication is that lysergic acid, which most researchers had treated as a breakdown product of limited importance, might be a direct contributor to the disease. The rumen essentially converts the complex alkaloids into lysergic acid, which then crosses into the bloodstream. This has practical consequences: selecting fescue varieties with novel endophytes that produce fewer or no ergot alkaloids has become a major focus in forage science.
Making Lysergic Acid in the Lab
Synthesizing lysergic acid from scratch has been one of the enduring challenges of organic chemistry. The first total synthesis was accomplished by R.B. Woodward and collaborators in 1954.20Journal of the American Chemical Society. The Total Synthesis of Lysergic Acid The molecule’s four fused rings, its stereochemistry, and the sensitivity of the indole system make it an unusually difficult target. Over the decades, several strategic approaches have been developed, using different intermediates and coupling methods to piece the rings together.21PubMed Central. Methods of Lysergic Acid Synthesis-The Key Ergot Alkaloid
Despite these advances, chemical synthesis remains impractical for large-scale production. The yields are too low and the steps too many. Industrial production of lysergic acid and its derivatives has historically relied on fermenting Claviceps fungi in large bioreactors, essentially coaxing the mold to produce what chemists cannot efficiently make. But fungal fermentation has its own problems: the organisms are slow-growing, hard to genetically modify, and finicky about culture conditions.
A more recent approach has been to transplant the entire biosynthetic pathway into baker’s yeast, an organism that grows quickly and is far easier to engineer. In 2022, researchers successfully reconstructed all eight enzymes of the lysergic acid pathway in yeast and achieved production of about 1.7 milligrams per liter in a one-liter bioreactor.22PubMed Central. Reconstituting the complete biosynthesis of D-lysergic acid in yeast That number is still far from commercially viable, but it demonstrates that biological production from sugar in an engineered host is feasible. Optimizing the pathway, improving enzyme activity, and scaling up fermentation could eventually provide a more reliable and controllable supply of lysergic acid for pharmaceutical manufacturing.
How Forensic Labs Detect It
Because LSD is active at such tiny doses, detecting it and its metabolites in biological samples is a serious analytical challenge. A typical dose of LSD is measured in micrograms, and the concentrations that show up in blood or urine afterward are extraordinarily low. The gold standard for forensic detection is liquid chromatography coupled with tandem mass spectrometry, which has been identified as the most sensitive and widely validated technique for LSD analysis across different sample types.23PubMed. Advances and Challenges in LSD Detection: Analytical Techniques, Matrix Selection, and Validation Gaps in Forensic Toxicology
In workplace drug-testing programs, the primary target is not LSD itself but its main urinary metabolite, 2-oxo-3-hydroxy-LSD. Validated methods using automated sample preparation can detect both LSD and this metabolite at concentrations as low as 0.05 nanograms per milliliter of urine.24PubMed. Quantitative Analysis of Lysergic Acid Diethylamide and Metabolite in Urine by Automated Extraction and Liquid Chromatography-Tandem Mass Spectrometry For field use, researchers have developed a hybrid method that combines a classic colorimetric spot test (the Ehrlich reagent, which turns purple in the presence of indole compounds) with electrochemical detection on disposable screen-printed electrodes. This gives investigators three independent signals for identifying LSD in seized samples without needing a full laboratory setup, though confirmatory testing still requires mass spectrometry.25Microchemical Journal. Enhanced detection of lysergic acid diethylamide using Ehrlich reagent and screen-printed electrodes: A hybrid method for application in forensic analysis
The analytical difficulty cuts both ways. The instability of LSD in stored samples, its rapid metabolism, and the vanishingly small quantities involved mean that false negatives are more common than with most other drugs of abuse. A negative test does not necessarily mean the person did not take LSD; it may mean the window for detection had already closed. This is a persistent gap in forensic toxicology that newer methods are still working to narrow.
Morning Glory Seeds and Seed-to-Seedling Alkaloid Shifts
One of the more curious aspects of ergot alkaloid biology in plants is how the compounds redistribute as a seed germinates. In several Ipomoea species, the alkaloids start concentrated in the seed but do not simply dilute as the seedling grows. Different types of alkaloids go to different parts of the plant. In species like Ipomoea tricolor, lysergic acid amides were allocated preferentially to the roots, while simpler clavine alkaloids stayed in the cotyledons (the seed leaves).26PubMed. Differential allocation of seed-borne ergot alkaloids during early ontogeny of morning glories (Convolvulaceae) This differential allocation suggests the plant is actively sorting its chemical defenses, possibly placing the compounds where they will do the most good against soil-dwelling herbivores or pathogens. It is a small detail, but it hints at a more sophisticated chemical ecology than you might expect from a garden vine.